← Leaderboards
Felicite K Noubissi
University Of Wisconsin-Madison
$1,513,144
Attributed
$1,513,144
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $193.8K · FY2010–25$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,513,144 · 4
By mechanism
U54$872,577 · 1
R21$350,443 · 1
R16$146,280 · 1
R03$143,844 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Donna M Peters$14,152,885
- Franz J Himpsel$11,190,180
- Mark D Hill$6,648,179
- Azadeh Davoodi$2,087,167
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSignal PathwaySignal TransductionMouse ModelAutomobile DrivingMalignant NeoplasmsMolecularPreventReportingApoptoticKnock-OutApoptosisCellsPharmaceutical PreparationsTumorIn VivoResistanceNovel TherapeuticsUnited StatesNovel Drug ClassKnockout MiceCancer CellGenesExhibits
Grant awards (10)
Colorectal Cancer Treatment and Drug Resistance; the Role of IGF2BP1$146,280
R16 · FY2025 · GM · contact PI
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis$193,281
U54 · FY2024 · MD · contact PI
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis$109,537
U54 · FY2023 · MD · contact PI
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis$187,510
U54 · FY2022 · MD · contact PI
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis$193,282
U54 · FY2021 · MD · contact PI
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis$188,967
U54 · FY2020 · MD · contact PI
A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP$75,473
R03 · FY2019 · CA · contact PI
A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP$68,371
R03 · FY2018 · CA · contact PI
Role of CRD-BP in Basal Cell Carcinoma Development$156,650
R21 · FY2011 · CA · contact PI
Role of CRD-BP in Basal Cell Carcinoma Development$193,793
R21 · FY2010 · CA · contact PI